期刊文献+

冠心病患者血清C3和CRP的水平分析 被引量:2

Complement C3 and C-reactive protein levels in patients with coronary artery disease
下载PDF
导出
摘要 目的了解C3、CRP与冠心病(CAD)的相关性。方法测定40名病人(经冠状动脉造影术确诊为典型冠心病)及40名年龄、性别相当的正常对照人群的血清C3、CRP、CHO、TG、HDL、LDL及空腹血糖水平。结果病人组的C3、CRP水平明显高于正常对照组(C3分别为2.94g/l和1.43g/l,P<0.001;CRP分别为19.32mg/l和5.71mg/l,P=0.005)。通过包括C3、CRP、CHO、TG、HDL、LDL及空腹血糖等参数的相关分析,C3与冠心病是独立相关的。结论CAD病人血清C3和CRP水平是升高的,且C3比CRP具有更好的相关性。 Objective The aim of this study was to determine the correlation between complement C3、CRP and coronary artery disease(CAD).Method We measured plasma C3、CRP、CHO、TG、HDL、LDL and fasting blood glucose levels in 40 patients undergoing coronary angiography for typical symptoms of CAD and 40 healthy age and sex matched controls.Results C3 levels were significantly higher in patients compared with controls(2.94g/l and 1.43 g/l respectively;p<0.001).CRP levels were also higher in patients compared with controls(19.32mg/l and 5.71mg/l respectively;p=0.005).In a correlation analysis model including C3、CRP、CHO、TG、 HDL、LDL and fastmg blood glucose,C3 was independently associated with CAD.Conclusion Both C3 and CRP plasma levels are elevated in patients with symptoms of CAD.However,C3 seems to be a better indicator of CAD than CRP in this study.
出处 《医学检验与临床》 2007年第4期39-40,38,共3页 Medical Laboratory Science and Clinics
关键词 C3 CRP 冠心病 炎症 心肌梗死 C3 CRP Coronary artery disease Inflammation Myocardial infarction
  • 相关文献

参考文献12

  • 1Sean P. Mazer,LeRoy E. Rabbani.Evidence for C-Reactive Protein’s Role in (CRP) Vascular Disease: Atherothrombosis, Immuno-Regulation and CRP[J]. Journal of Thrombosis and Thrombolysis . 2004 (2)
  • 2Alper CA,Johnson AM,Birtch AG et al.Human C3:evidence for theliver as the primary site of synthesis. Science . 1969
  • 3Libby P,Ridker PM.Inflammation and atherosclerosis:role of C-reactiveprotein in risk assessment. The American Journal of Medicine . 2004
  • 4Bhakdi S,Lackner KJ,Han SR et al.Beyond cholesterol:the enigma ofatherosclerosis revisited. Thrombosis and Haemostasis . 2004
  • 5Yasojima K,Schwab C,McGeer EG et al.Complement components,butnot complement inhibitors,are upregulated in atherosclerotic plaques. Arteriosclerosis Thrombosis and Vascular Biology . 2001
  • 6Onat A,Uzunlar B,Hergenc G et al.Crosssectional study of complemcntC3 as a coronary risk factor among men and women. Clinical Science . 2005
  • 7Mazer SP,Rabbani LE.Evidence for C-reactive protein’s role in(CRP)vascular disease:atherothrombosis,immuno-regulmion and CRP. Journal of Thrombosis and Thrombolysis . 2004
  • 8Ridker PM,Wilson PW,Grundy SM.Should C-reactive protein beadded to metabolic syndrome and to assessment of global cardiovascularrisk. Circulation . 2004
  • 9Buono C,Come CE,Witztum JL et al.Influence of C3 deficiency onatherosclerosis. Circulation . 2002
  • 10Szeplaki G,Prohaszka Z,Duba J et al.Association of high serum concen-tration of the third component of complement(C3)with pre-existing se-vere coronary artery disease and new vascular events in women. Therosclerosis . 2004

同被引文献47

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部